http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102614460-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b8f80592dee1104108a83a72cd99152 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2012-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d7039b4dbc44ccc1897d6db6fb6fed |
| publicationDate | 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102614460-B |
| titleOfInvention | Chinese medicinal composition for treating myocardial infarction and preparation method thereof |
| abstract | The invention discloses a Chinese medicinal composition for treating myocardial infarction. The Chinese medicinal composition is prepared from the following Chinese herbal medicines in part by weight: 2 to 6 parts of American ginseng, 20 to 45 parts of astragalus, 2 to 6 parts of saffron, 20 to 45 parts of root of red-rooted salvia, 20 to 45 parts of snakegourd fruit, 6 to 15 parts of turmeric root tuber, 20 to 45 parts of barley malt, 2 to 6 parts of dalbergia wood, 6 to 15 parts of dwarf lilyturf root, and 0.05 to 0.5 part of borneol. The medicament sources are readily available, the costs of the medicinal materials are low, and the burden of the patients can be lightened. The selected materials are traditional Chinese medicinal materials, so the composition does not have any toxic or side effect. |
| priorityDate | 2012-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.